CEDAR.Co.,Ltd. (TYO:2435)
Japan · Delayed Price · Currency is JPY 217.00
-6.00 (-2.69%)
Sep 12, 2025, 3:30 PM JST
CEDAR.Co.,Ltd. Revenue
CEDAR.Co.,Ltd. had revenue of 4.50B JPY in the quarter ending June 30, 2025, with 1.42% growth. This brings the company's revenue in the last twelve months to 17.89B, up 2.45% year-over-year. In the fiscal year ending March 31, 2025, CEDAR.Co.,Ltd. had annual revenue of 17.83B with 3.03% growth.
Revenue (ttm)
17.89B
Revenue Growth
+2.45%
P/S Ratio
0.14
Revenue / Employee
13.36M
Employees
1,339
Market Cap
2.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.83B | 525.00M | 3.03% |
| Mar 31, 2024 | 17.30B | 862.00M | 5.24% |
| Mar 31, 2023 | 16.44B | 693.00M | 4.40% |
| Mar 31, 2022 | 15.75B | 136.00M | 0.87% |
| Mar 31, 2021 | 15.61B | 481.00M | 3.18% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| HOYA Corporation | 876.09B |
| Takeda Pharmaceutical Company | 4,480.25B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |